Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jun 1;97(11):2601–2610. doi: 10.1172/JCI118709

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

H O Steinberg 1, H Chaker 1, R Leaming 1, A Johnson 1, G Brechtel 1, A D Baron 1
PMCID: PMC507347  PMID: 8647954

Abstract

To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of methacholine chloride (MCh) or sodium nitroprusside (SNP) during saline infusion and euglycemic hyperinsulinemia in lean insulin-sensitive controls (C), in obese insulin-resistant subjects (OB), and in subjects with non-insulin-dependent diabetes mellitus (NIDDM). MCh induced increments in LBF were approximately 40% and 55% lower in OB and NIDDM, respectively, as compared with C (P < 0.05). Euglycemic hyperinsulinemia augmented the LBF response to MCh by - 50% in C (P < 0.05 vs saline) but not in OB and NIDDM. SNP caused comparable increments in LBF in all groups. Regression analysis revealed a significant inverse correlation between the maximal LBF change in response to MCh and body fat content. Thus, obesity/insulin resistance is associated with (a) blunted endothelium-dependent, but normal endothelium-independent vasodilation and (b) failure of euglycemic hyperinsulinemia to augment endothelium-dependent vasodilation. Therefore, obese/insulin-resistant subjects are characterized by endothelial dysfunction and endothelial resistance to insulin's effect on enhancement of endothelium-dependent vasodilation. This endothelial dysfunction could contribute to the increased risk of atherosclerosis in obese insulin-resistant subjects.

Full Text

The Full Text of this article is available as a PDF (199.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. A., Hoffman R. P., Balon T. W., Sinkey C. A., Mark A. L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991 Jun;87(6):2246–2252. doi: 10.1172/JCI115260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baron A. D., Brechtel-Hook G., Johnson A., Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. 1993 Feb;21(2):129–135. doi: 10.1161/01.hyp.21.2.129. [DOI] [PubMed] [Google Scholar]
  3. Baron A. D., Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol. 1993 Jul;265(1 Pt 1):E61–E67. doi: 10.1152/ajpendo.1993.265.1.E61. [DOI] [PubMed] [Google Scholar]
  4. Baron A. D., Brechtel G., Wallace P., Edelman S. V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988 Dec;255(6 Pt 1):E769–E774. doi: 10.1152/ajpendo.1988.255.6.E769. [DOI] [PubMed] [Google Scholar]
  5. Baron A. D., Steinberg H., Brechtel G., Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol. 1994 Feb;266(2 Pt 1):E248–E253. doi: 10.1152/ajpendo.1994.266.2.E248. [DOI] [PubMed] [Google Scholar]
  6. Björntorp P. Abdominal obesity and risk. Clin Exp Hypertens A. 1990;12(5):783–794. doi: 10.3109/10641969009073499. [DOI] [PubMed] [Google Scholar]
  7. Bruckdorfer K. R., Jacobs M., Rice-Evans C. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis. Biochem Soc Trans. 1990 Dec;18(6):1061–1063. doi: 10.1042/bst0181061. [DOI] [PubMed] [Google Scholar]
  8. Calver A., Collier J., Moncada S., Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992 Sep;10(9):1025–1031. [PubMed] [Google Scholar]
  9. Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992 Dec;90(6):2548–2554. doi: 10.1172/JCI116149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chait A., Brazg R. L., Tribble D. L., Krauss R. M. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993 Apr;94(4):350–356. doi: 10.1016/0002-9343(93)90144-e. [DOI] [PubMed] [Google Scholar]
  11. Chin J. H., Azhar S., Hoffman B. B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992 Jan;89(1):10–18. doi: 10.1172/JCI115549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Creager M. A., Cooke J. P., Mendelsohn M. E., Gallagher S. J., Coleman S. M., Loscalzo J., Dzau V. J. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990 Jul;86(1):228–234. doi: 10.1172/JCI114688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Creager M. A., Gallagher S. J., Girerd X. J., Coleman S. M., Dzau V. J., Cooke J. P. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992 Oct;90(4):1248–1253. doi: 10.1172/JCI115987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Davda R. K., Stepniakowski K. T., Lu G., Ullian M. E., Goodfriend T. L., Egan B. M. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995 Nov;26(5):764–770. doi: 10.1161/01.hyp.26.5.764. [DOI] [PubMed] [Google Scholar]
  15. Dustan H. P. Obesity and hypertension. Ann Intern Med. 1985 Dec;103(6 ):1047–1049. doi: 10.7326/0003-4819-103-6-1047. [DOI] [PubMed] [Google Scholar]
  16. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350–357. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  17. Ferri C., Carlomagno A., Coassin S., Baldoncini R., Cassone Faldetta M. R., Laurenti O., Properzi G., Santucci A., De Mattia G. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care. 1995 Feb;18(2):226–233. doi: 10.2337/diacare.18.2.226. [DOI] [PubMed] [Google Scholar]
  18. Ferri C., Pittoni V., Piccoli A., Laurenti O., Cassone M. R., Bellini C., Properzi G., Valesini G., De Mattia G., Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab. 1995 Mar;80(3):829–835. doi: 10.1210/jcem.80.3.7883838. [DOI] [PubMed] [Google Scholar]
  19. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  20. Groop L. C., Bonadonna R. C., Simonson D. C., Petrides A. S., Shank M., DeFronzo R. A. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol. 1992 Jul;263(1 Pt 1):E79–E84. doi: 10.1152/ajpendo.1992.263.1.E79. [DOI] [PubMed] [Google Scholar]
  21. Gupta S., McArthur C., Grady C., Ruderman N. B. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol. 1994 May;266(5 Pt 2):H2146–H2151. doi: 10.1152/ajpheart.1994.266.5.H2146. [DOI] [PubMed] [Google Scholar]
  22. Haffner S. M., Mitchell B. D., Valdez R. A., Hazuda H. P., Morales P. A., Stern M. P. Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Am J Hypertens. 1992 Mar;5(3):147–153. doi: 10.1093/ajh/5.3.147. [DOI] [PubMed] [Google Scholar]
  23. Hogg N., Kalyanaraman B., Joseph J., Struck A., Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 1993 Nov 15;334(2):170–174. doi: 10.1016/0014-5793(93)81706-6. [DOI] [PubMed] [Google Scholar]
  24. Ignarro L. J. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension. 1990 Nov;16(5):477–483. doi: 10.1161/01.hyp.16.5.477. [DOI] [PubMed] [Google Scholar]
  25. Jessup W. Cellular modification of low-density lipoproteins. Biochem Soc Trans. 1993 May;21(2):321–325. doi: 10.1042/bst0210321. [DOI] [PubMed] [Google Scholar]
  26. Jessup W., Dean R. T. Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis. Atherosclerosis. 1993 Jul;101(2):145–155. doi: 10.1016/0021-9150(93)90111-7. [DOI] [PubMed] [Google Scholar]
  27. Johnstone M. T., Creager S. J., Scales K. M., Cusco J. A., Lee B. K., Creager M. A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993 Dec;88(6):2510–2516. doi: 10.1161/01.cir.88.6.2510. [DOI] [PubMed] [Google Scholar]
  28. Laakso M., Edelman S. V., Brechtel G., Baron A. D. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 1990 Jun;85(6):1844–1852. doi: 10.1172/JCI114644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Laakso M., Edelman S. V., Brechtel G., Baron A. D. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992 Sep;41(9):1076–1083. doi: 10.2337/diab.41.9.1076. [DOI] [PubMed] [Google Scholar]
  30. Liao J. K., Shin W. S., Lee W. Y., Clark S. L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995 Jan 6;270(1):319–324. doi: 10.1074/jbc.270.1.319. [DOI] [PubMed] [Google Scholar]
  31. Lüscher T. F., Dohi Y., Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19 (Suppl 5):S34–S42. [PubMed] [Google Scholar]
  32. Lüscher T. F. Functional abnormalities of the vascular endothelium in hypertension and atherosclerosis. Scand J Clin Lab Invest Suppl. 1990;199:28–32. [PubMed] [Google Scholar]
  33. McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992 Aug;35(8):771–776. doi: 10.1007/BF00429099. [DOI] [PubMed] [Google Scholar]
  34. Mollace V., Salvemini D., Anggard E., Vane J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol. 1991 Nov;104(3):633–638. doi: 10.1111/j.1476-5381.1991.tb12481.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Moncada S., Palmer R. M., Higgs E. A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988 Oct;12(4):365–372. doi: 10.1161/01.hyp.12.4.365. [DOI] [PubMed] [Google Scholar]
  36. NOVAK M. COLORIMETRIC ULTRAMICRO METHOD FOR THE DETERMINATION OF FREE FATTY ACIDS. J Lipid Res. 1965 Jul;6:431–433. [PubMed] [Google Scholar]
  37. Panza J. A., Casino P. R., Badar D. M., Quyyumi A. A. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 1993 May;87(5):1475–1481. doi: 10.1161/01.cir.87.5.1475. [DOI] [PubMed] [Google Scholar]
  38. Panza J. A., Casino P. R., Kilcoyne C. M., Quyyumi A. A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993 May;87(5):1468–1474. doi: 10.1161/01.cir.87.5.1468. [DOI] [PubMed] [Google Scholar]
  39. Panza J. A., Quyyumi A. A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990 Jul 5;323(1):22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
  40. Paternò R., Faraci F. M., Heistad D. D. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke. 1994 Dec;25(12):2457–2462. doi: 10.1161/01.str.25.12.2457. [DOI] [PubMed] [Google Scholar]
  41. Radomski M. W., Palmer R. M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987 Nov;92(3):639–646. doi: 10.1111/j.1476-5381.1987.tb11367.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  43. Reaven G. M., Chen Y. D., Jeppesen J., Maheux P., Krauss R. M. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993 Jul;92(1):141–146. doi: 10.1172/JCI116541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Reaven G. M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–131. doi: 10.1146/annurev.me.44.020193.001005. [DOI] [PubMed] [Google Scholar]
  45. Rizza R. A., Mandarino L. J., Gerich J. E. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981 Jun;240(6):E630–E639. doi: 10.1152/ajpendo.1981.240.6.E630. [DOI] [PubMed] [Google Scholar]
  46. Scherrer U., Randin D., Vollenweider P., Vollenweider L., Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994 Dec;94(6):2511–2515. doi: 10.1172/JCI117621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shamiss A., Carroll J., Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens. 1992 Jan;5(1):26–28. doi: 10.1093/ajh/5.1.26. [DOI] [PubMed] [Google Scholar]
  48. Steinberg H. O., Brechtel G., Johnson A., Fineberg N., Baron A. D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994 Sep;94(3):1172–1179. doi: 10.1172/JCI117433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stepniakowski K. T., Goodfriend T. L., Egan B. M. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr;25(4 Pt 2):774–778. doi: 10.1161/01.hyp.25.4.774. [DOI] [PubMed] [Google Scholar]
  50. Taddei S., Virdis A., Mattei P., Ghiadoni L., Gennari A., Fasolo C. B., Sudano I., Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995 Apr 1;91(7):1981–1987. doi: 10.1161/01.cir.91.7.1981. [DOI] [PubMed] [Google Scholar]
  51. Takahashi H., Nakanishi T., Nishimura M., Tanaka H., Yoshimura M. Measurements of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J Cardiovasc Pharmacol. 1992;20 (Suppl 12):S214–S216. doi: 10.1097/00005344-199204002-00061. [DOI] [PubMed] [Google Scholar]
  52. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989 Oct 28;2(8670):997–1000. doi: 10.1016/s0140-6736(89)91013-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES